KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)R&D In ProcessReceivables - NetShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

AbbVie (ABBV) Cost of Revenue (2016 - 2026)

AbbVie has reported Cost of Revenue over the past 14 years, most recently at $4.6 billion for Q4 2025.

  • Quarterly Cost of Revenue rose 3.55% to $4.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $18.2 billion through Dec 2025, up 7.69% year-over-year, with the annual reading at $18.2 billion for FY2025, 7.69% up from the prior year.
  • Cost of Revenue was $4.6 billion for Q4 2025 at AbbVie, down from $5.3 billion in the prior quarter.
  • Over five years, Cost of Revenue peaked at $6.5 billion in Q3 2023 and troughed at $4.0 billion in Q1 2023.
  • The 5-year median for Cost of Revenue is $4.3 billion (2021), against an average of $4.5 billion.
  • Year-over-year, Cost of Revenue soared 116.94% in 2021 and then tumbled 35.05% in 2024.
  • A 5-year view of Cost of Revenue shows it stood at $4.3 billion in 2021, then fell by 3.47% to $4.2 billion in 2022, then surged by 36.79% to $5.7 billion in 2023, then fell by 22.93% to $4.4 billion in 2024, then grew by 3.55% to $4.6 billion in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Cost of Revenue are $4.6 billion (Q4 2025), $5.3 billion (Q3 2025), and $4.3 billion (Q2 2025).